axicabtagene ciloleucel,tisagenlecleucel
daiichi sankyo,novartis,gilead
['axicel', 'axi-cel', 'tisa-cel', 'dlbcl', 'tisacel']
#ash22, spanish data, n=407 in r/r dlbcl, pt who met or did not meet scholar 1 criteria for refractory disease: axicel outcones &gt; tisacel outcomes, with more toxicities 
MD